Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-01-18-Speech-3-360-000"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20120118.26.3-360-000"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
".
Madam President, I would like to thank Ms Klaß for the work she has done here. It was certainly a very difficult dossier, and we spent a long time grappling with it before we found a common line, particularly among the different groups.
Biocidal products must, by their very nature, involve active substances that entail a certain amount of danger, otherwise they would not have any effect. Achieving the balance is the big challenge. Our consumers cannot understand why many active substances should be more dangerous in some Member States than in others. Therefore, it is also important from the point of view of the single market that we put this European authorisation system in place here. It is very important that we make progress in this regard and make it clear to consumers that the single market should apply in this important area, too, and what is dangerous and prohibited in Denmark should not be authorised in other Member States like Italy or Portugal, either. We have also clearly defined the substances for which we are prepared to accept exceptions, so that Member States that want to go a step further are actually able to do so. We have surely therefore fulfilled our task of ensuring a high level of environmental and consumer protection while, on the other hand, also recognising the special characteristics of the Member States.
The importance of this matter is also demonstrated by the fact that, these days, we can probably say that there is hardly anything that we handle in our day-to-day lives that is not treated with these substances. There have also been rumours recently that there are problems in various hotels in this wonderful city, where certain small animals are seemingly terrorising the place. Here, too, we see that it is perhaps necessary to do something to combat these animals. I just mention this in passing.
The fact is, we want to create this single market. It is also the case that we are in favour of all products that are placed on our market only being permitted to be treated with substances that have a European authorisation. Thus, no preference is being shown here to imported goods. That is also important for our consumers to know.
We have also tightened up the requirements relating to animal experiments. In this regard, results obtained by other producers must also be incorporated so that as few animals as possible are used.
Overall, this is a perfect compromise. I think all of the groups have worked well together, and Ms Klaß has done a very good job here."@en1
|
lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples